Test time has arrived: the first person has been treated in a highly anticipated gene therapy trial that aims to coax aged ...

Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

The approach relies on “reprogramming” cells to a younger state. It’s one of many strategies being explored by biotech ...

Researchers at Tianjin First Central Hospital took fat cells from the woman who had been living with Type 1 diabetes for over ...

A team led by researchers has discovered that a group of cells located in the skin and other areas of the body, called neural crest stem cells, are the source of reprogrammed neurons found by other ...

Reprogram Biosciences, a preclinical oncology biotechnology company developing mRNA-based therapeutics to treat solid tumors, today announced the close of its seed financing. The close brings total ...

Leuven, 11 March 2025 – Solid tumors often provide a challenging environment for the T cells of our immune system. By reprogramming the metabolism of T cells, scientists at the VIB-KU Leuven Center ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in pancreatic cancer—and identified a promising strategy to overcome that resistance.